Pedro Ventura-Aguiar

TL;DR: A case of a COVID‐19 infection in a solid organ transplant recipient, in which the first clinical symptoms were of gastrointestinal viral disease and fever, which further progressed to respiratory symptoms in 48 hours, suggests protocols for screening for SARS‐Cov2 may be needed to be re‐evaluated.

TL;DR: In this article, the mRNA-1273 SARS-CoV-2 vaccine elicits either cellular or humoral response in almost two thirds of kidney transplant recipients, while the vaccine unresponsiveness was associated with diabetes and treatment with anti-thymocyte globulins during the last year.

TL;DR: This work reviews mTOR inhibitors safety profile for adult organ transplantation, ranging from acute side effects, such as lymphoceles, delayed wound healing, or cytopenias, to long-term ones which increase morbidity and mortality,such as cancer risk and metabolic profile.

TL;DR: Although patients who died presented with worse respiratory situation at admission, this was not significantly different at tocilizumab administration and did not have an impact on outcome in the multivariate analysis.

TL;DR: In this cohort, ARDS was equally present among young and old kidney recipients, however, the elderly might be at higher risk of death, along with those showing higher baseline LDH at admission, and those show higher baseline lactate dehydrogenase at admission.